Specialty Pharma Stocks Surge on 'HUGE' Election Win

November 9, 2016 8:46 AM EST
Get Alerts MYL Hot Sheet
Price: $35.99 -0.11%

Rating Summary:
    12 Buy, 12 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 11 | Down: 31 | New: 42
Trade MYL Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

Specialty Pharmaceuticals stocks are sharply higher after a Trump win, House and Senate stay Republican and Proposition 61 in California was defeated.

Commenting on the results, Wells Fargo's David Maris said: "Overall, we believe the election results should provide a boost to pharmaceutical company investor sentiment. One will have to wait to see if Trump is serious about his anti-inversion rhetoric which was strong during the campaign, but overall, we think many healthcare investors thought that the election was going to turn out very differently and as such, we believe a relief rally in the sector seems likely, as pharmaceutical industry legislative risks are significantly diminished with the results."

  • Shire plc (NASDAQ: SHPG) +7.7%
  • Mallinckrodt (NYSE: MNK) +7.5%
  • Teva (NASDAQ: TEVA) +7.3%
  • Mylan (NASDAQ: MYL) +5.9%
  • Horizon Pharma (NASDAQ: HZNP) +5.7%
  • Concordia International (NASDAQ: CXRX) +5.5%
  • Endo International (NASDAQ: ENDP) +3.5%
  • Valeant (NYSE: VRX) +3.1%
  • Depomed (NASDAQ: DEPO) +2.6%





Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Analyst Comments, Trader Talk

Related Entities

Wells Fargo, David Maris

Add Your Comment